Tue.Jul 26, 2022

article thumbnail

Illinois Bill Allows Pharmacists to Prescribe HIV Pre-, Post-Exposure Prophylaxis Drugs, Testing

Pharmacy Times

The bill allows pharmacists to dispense and administer drugs, order laboratory tests, and consult patients on HIV pre- and post-exposure drugs.

149
149
article thumbnail

Macmillan alliance will provide digital health apps to cancer patients

pharmaphorum

Newly diagnosed cancer patients across the UK will get free access to digital mental health therapies, thanks to a new partnership between Macmillan Cancer Support and Big Health. The alliance, billed as the first of its kind in the UK, means that cancer patients will be able to use Big Health apps like Sleepio and Daylight, which aim to treat insomnia and anxiety using cognitive behavioural therapy (CBT) techniques.

134
134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Inaccurate Labeling, Misleading Claims Found Among CBD Products

Pharmacy Times

A variety of cannabidiol (CBD) products incorrectly listed their CBD and tetrahydrocannabinol content, in addition to making therapeutic and cosmetic claims without FDA approval.

Labelling 123
article thumbnail

Entrance of novel therapies will drive Niemann-Pick type C disease market growth

Pharmaceutical Technology

According to GlobalData’s recent Niemann-Pick Type C (NPC): Opportunity Analysis and Forecast to 2031 report, the NPC market is expected to see significant growth during 2021–31. The three major markets (3MM: the US, Germany and the UK) will increase in market size from $128.35m last year to $188.35m in 2031, at a compound annual growth rate (CAGR) of 3.9%.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Progress Towards Combatting Issues in Independent Pharmacy

Pharmacy Times

Whether it was the ability to vaccinate, whether it was the ability to test, whether it's now the ability to prescribe Paxlovid for patients, those are big progress moves for the profession of pharmacy.

article thumbnail

CHMP meeting highlights – July 2022

European Pharmaceutical Review

Recommended for approval. Amvuttra * (vutrisiran) was recommended for marketing authorisation as a treatment for adults with hereditary transthyretin-mediated amyloidosis, a rare life-threatening disease that damages multiple nerves across the body. The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Celdoxome pegylated liposomal (doxorubicin hydrochloride) for the treatment of metastatic breast cancer, advanced ovaria

More Trending

article thumbnail

Art contest aims to build awareness of clinical trial opportunities

Outsourcing Pharma

Bridging the Gap for Clinical Trials is a free competition designed to employ artistic expression to dispel misinformation start positive conversations.

97
article thumbnail

COVID Vaccination Prevented Infection, Reduced Absence for Health Care Workers During Second Wave, Studies Find

Pharmacy Times

COVID-19 vaccination averted infection in 10% of NHS health care workers and reduced absence from work by nearly 70%.

Vaccines 115
article thumbnail

Ginkgo to acquire Zymergen for $300m

Pharmaceutical Technology

Ginkgo Bioworks has signed a definitive agreement for the acquisition of biotechnology company Zymergen in an all-stock deal worth nearly $300m. According to the agreement, 5.25% of the pro forma merged business will be owned by the stockholders of Zymergen following the acquisition. The deal to combine two complementary companies with identical visions is anticipated to expedite the development of the innovative horizontal synthetic biology platform of Ginkgo.

64
article thumbnail

COVID-19 Booster Rates Low Among US Veterans, Study Finds

Pharmacy Times

Fewer than half of eligible veterans enrolled in the Veterans Health Administration have received their COVID-19 booster.

111
111
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

North America is seeing a hiring boom in pharmaceutical industry fintech roles

Pharmaceutical Technology

North America was the fastest growing region for fintech hiring among pharmaceutical industry companies in the three months ending May. The number of roles in North America made up 18.2% of total fintech jobs - up from 0% in the same quarter last year. That was followed by Europe, which saw a 2.3 year-on-year percentage point change in fintech roles.

59
article thumbnail

Pharmacy Care Management Can Address the Challenges of an Evolving Health Care Landscape

Pharmacy Times

When pharmacists are involved in the care process, they can address common barriers to medication use, such as polypharmacy, ineffective medication, high costs, health and lifestyle considerations, and social needs.

123
123
article thumbnail

NewAmsterdam Pharma enters merger deal with Frazier Lifesciences

Pharmaceutical Technology

NewAmsterdam Pharma has signed a definitive business combination agreement with special purpose acquisition company (SPAC) Frazier Lifesciences Acquisition (FLAC). The SPAC is sponsored by a Frazier Healthcare Partners affiliate. The deal will make NewAmsterdam Pharma a publicly listed company focusing on oral treatments for cardiometabolic diseases.

59
article thumbnail

Assessing the Shift in Global Health Care Equity Following the Peaks in the Devastation From COVID-19

Pharmacy Times

Daniel Gagnon, VP of Global UPS Healthcare, discusses vaccine equity panel discussion at the UPS Impact Summit in Atlanta, which was held at the National Center for Civil and Human Rights.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

World Hepatitis Day at Your Pharmacy

Digital Pharmacist

World Hepatitis Day occurs annually on July 28th, the birthday of Dr. Baruch Blumberg (1925–2011). Dr. Blumberg discovered the hepatitis B virus in 1967 and 2 years later developed the first hepatitis B vaccine. On World Hepatitis Day, organizations around the world, including WHO and the CDC, raise awareness about viral hepatitis. This day brings education around the disease state, creates awareness on the number of people affected by it, and discusses what can be done to prevent future infecti

article thumbnail

Daily Medication Pearl: Tapinarof (Vtama)

Pharmacy Times

Tapinarof (Vtama) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of plaque psoriasis in adults.

65
article thumbnail

Realising the promise of cancer vaccines

pharmaphorum

For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. And for good reason. The concept of pre-emptively training the immune system to increase the frequencies of tumour-reactive T cells could be game-changing for cancer patients worldwide. Preventative vaccines have already proven to be highly effective against certain cancer types.

article thumbnail

Pipeline Treatments for Patients With MCL

Pharmacy Times

Drs Haumschild, Jain, and Wang evaluate MCL therapies under investigation and the impact on the future of MCL treatment.

65
article thumbnail

Magazine: Genomic projects exploit scale as clinical applications play catch-up

Pharmaceutical Technology

The last few months have marked the publication of research emerging from projects designed to collect and analyse genomic data on a wider scale than was previously thought possible. Scientists are not just studying specific mutations associated with medical conditions, but also establishing frameworks to understand the role of chromosomal instability and copy number changes in driving those disorders.

52
article thumbnail

Study: Pregnant African Women With COVID-19 Have Double Risk of ICU Admission

Pharmacy Times

Results of analysis also show they have a much higher incidence of dying in the hospital than those without the virus.

article thumbnail

NewAmsterdam goes public to advance drug in abandoned class

pharmaphorum

NewAmsterdam Pharma has charted out a route to a Nasdaq listing by merging with black cheque company Frazier Lifesciences in a deal that will provide additional cash for its main drug candidate – oral CETP inhibitor obicetrapib. Remember CETP? It was a hot topic in cholesterol-lowering drug development a few years ago, but when Merck & Co finally pulled the plug on anacetrapib five years ago on lacklustre phase 3 data, the general consensus was that the drug class was an R&D dead end.

52
article thumbnail

Future Direction and Unmet Needs in Treatment of Mantle Cell Lymphoma

Pharmacy Times

The experts provide their closing thoughts and discuss unmet needs in the treatment of patients with MCL.

65
article thumbnail

5th Annual Targeted Protein Degradation Summit

pharmaphorum

The 5th Annual Targeted Protein Degradation Summit returns to Boston as the most comprehensive, definitive event of the year, uniting 700+ large pharma, innovative biotech and world-renowned academics to discuss the full breadth of protein degrader drug development. With 85+ world-class speakers delivering their latest findings, join them for 4 days of cutting-edge science, ample networking opportunities and a plethora of interactive sessions to fuel you and your team towards achieving your 2022

52
article thumbnail

July 2022: OTC Product News

Pharmacy Times

This month's featured products include prenatal supplements, an intensive hydrating serum, and more.

65
article thumbnail

Novartis takes aim at MS blockbuster Tysabri in US and Europe

pharmaphorum

Regulators in the US and Europe have started to review Novartis’ biosimilar version of Biogen’s big-selling multiple sclerosis therapy Tysabri, which could reach the market next year. If approved, the Tysabri (natalizumab) biosimilar – originally developed by Polpharma Biologics – will be sold by Novartis’ Sandoz unit for all of the originator drug’s indications in the two markets, which span relapsing-remitting MS (RRMS), active secondary progressive MS in adults, and Cr

FDA 52
article thumbnail

Aligning Value-Based Care with Payer Considerations In MCL Therapy Management

Pharmacy Times

Key opinion leaders evaluate treatment options for MCL while emphasizing payer considerations.

65
article thumbnail

Despite ban, Martin Shkreli can’t seem to kick the pharma habit

pharmaphorum

Given that Martin Shkreli has a lifetime restraining order preventing him from working in the pharma industry, it will raise a few eyebrows that his new company – launched just two months after his release from prison for securities fraud – is called ‘Druglike’ The new venture is described as developing a decentralised computing network that will be used to power early-stage drug discovery projects and – according to Shkreli – will “disrupt the economics of the drug business.&#

article thumbnail

Cancer Moonshot meeting brings together survivors, industry leaders

Outsourcing Pharma

The gathering, convened by patient advocacy group Fight Colorectal Cancer, responded to President Bidenâs call to improve screening and treatment options.

52
article thumbnail

Daily OTC Pearl: AfterBurn

Pharmacy Times

AfterBurn gel offers relief for sunburn, scalds, and other types of burns.

65
article thumbnail

Biogen gets much-needed pipeline lift with speedy ALS drug review

pharmaphorum

Beleaguered Biogen has been handed some encouraging news from the FDA, after the regulator agreed to complete its review of amyotrophic lateral sclerosis (ALS) therapy tofersen within six months. The priority review of the Ionis-partnered SOD-1-targeted antisense drug marks the latest stage in the resurrection of the programme, which was all-but written off last October when it failed a phase 3 trial.

FDA 45
article thumbnail

FDA Continues to Grapple with Accelerated Approval Issues

PharmExec

With debate swirling around products cleared through this pathway, reforms and tighter oversight likely.

FDA 52
article thumbnail

The Key Issues Facing Independent Pharmacy

Pharmacy Times

When we talk about access, that is a pharmacist.

article thumbnail

Iconovo receives $883,800 grant from the Bill & Melinda Gates Foundation

Pharma Times

Funding will develop inhaled therapies using ICOone Nasal in preparation for the next pandemic

51
article thumbnail

OTC Case Studies: Rhinitis

Pharmacy Times

How would you handle these patient questions?

65